colorectal neoplasia(endoscopically removed) Colon tumor
Conditions
Interventions
Colibactin positive patients are given biolactis (3 g/day) for 3 months.
Sponsors
Ishikawa Hideki
Watanabe Kenji
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with a history of colorectal tumor. 2) Those who are positive for colibactin producing bacteria twice consecutively. 3) Men and women over the age of 20 on the date of registration. 4) Written consent has been obtained by the patient prior to enrollment in the study.
Exclusion criteria
Exclusion criteria: 1) Drug allergy to lactic acid bacteria preparations. 2) Currently taking violactis. 3) Taking antibiotics. 4) For other safety reasons, the principal investigator determines that participation in this study is inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of colibactin-producing bacteria 90 days after the start of the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The presence or absence of detection of colibactin-producing bacteria in the stool 45 days after the start of administration, and evaluation of the amount of colibactin-producing bacteria over the entire period. | — |
Contacts
Public ContactHideki Ishikawa
Ishikawa Gastorintetinal Clinic
Outcome results
None listed